The FTC is closely watching healthcare deals such as CVS’ planned acquisition of Signify Health and Amazon’s planned acquisition of One Medical, which could potentially delay the deals from closing, Becker’s reports.
These deals are undergoing deep scrutiny from the FTC as investors have been increasingly cracking down on Big Tech mergers.
For example, on Sept. 2, 1Life Healthcare, which operates One Medical’s primary care clinics in 25 U.S. markets, said that One Medical and Amazon had received a request for more information about the planned $3.9 billion deal from the FTC.
The investigation, according to The Wall Street Journal, could delay the acquisition’s completion as U.S. antitrust probes, on average, take about 11 months. Read more.
